Hertzberg Richard

Average Profitability
<0.0001%
Insider Buys Quantity
12
Insider Buys Sum
$3.3M
Insider Sells Quantity
1
Insider Sells Sum
$42,609.00

Insider Activity of Hertzberg Richard

The largest purchase of all time was on 2014-08-20 and amounted to 409158 shares of Cellectar Biosciences, Inc. for $1.53M.

The largest sale of all time was on 2016-10-31 and amounted to 21000 shares of Cellectar Biosciences, Inc. for $42,609.

Biography of Hertzberg Richard

No biography is available at this moment.

2016-10-31SaleCellectar Biosciences, Inc.
CLRB
21,000
0.1919%
$2.03$42,609-9.19%
2016-04-21PurchaseCellectar Biosciences, Inc.
CLRB
7,516
0.1746%
$1.90$14,280+21.69%
2016-04-15PurchaseCellectar Biosciences, Inc.
CLRB
469,484
13.3261%
$2.58$1.21M+9.52%
2015-12-28PurchaseCellectar Biosciences, Inc.
CLRB
significant owner
75,000
0.899%
$0.72$54,000-60.71%
2015-12-24PurchaseCellectar Biosciences, Inc.
CLRB
significant owner
50,000
0.5683%
$0.79$39,500-65.99%
2015-12-22PurchaseCellectar Biosciences, Inc.
CLRB
significant owner
5,000
0.0576%
$0.91$4,550-70%
2015-12-16PurchaseCellectar Biosciences, Inc.
CLRB
significant owner
19,592
0.2361%
$0.91$17,829-67.5%
2015-12-11PurchaseCellectar Biosciences, Inc.
CLRB
significant owner
16,250
0.1988%
$0.92$15,015-66.48%
2015-12-08PurchaseCellectar Biosciences, Inc.
CLRB
significant owner
10,000
1.6054%
$12.00$120,000-65.63%
2014-10-03PurchaseCellectar Biosciences, Inc.
CLRB
significant owner
10,000
1.2385%
$12.00$120,000+34.83%
2014-09-19PurchaseCellectar Biosciences, Inc.
CLRB
significant owner
20,000
0.4036%
$2.67$53,400+7.58%
2014-08-20PurchaseCellectar Biosciences, Inc.
CLRB
significant owner
409,158
9.9072%
$3.75$1.53M-8.25%
2011-12-05PurchaseCellectar Biosciences, Inc.
CLRB
significant owner
10,000
0.5417%
$12.00$120,000+91.67%
Company
About Prismo.proPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.